Daniel Cohen
Co-founder, Chief Executive Officer

More than 30 years experience in academia, biotech and big pharma companies. Professor of Medical Genetics, founder of modern genetics, genomics and pharmacogenomics. Former CSO of Genset (acquired by Serono) and VP Genetics Worldwide of Serono Genetics Institute. Co-founder of Millennium Pharma, Genethon and the CEPH research institute. Author of 150 peer-reviewed publications.

Xavier Paoli
VP, Chief Commercial Officer

Held various marketing positions in biotech and big pharma companies (GlaxoSmithKline, UCB Pharma, Alexion). Brings 14 years of experience in the commercialization of innovative drugs notably for rare diseases. Graduated from HEC Paris with a Master of Marketing and from the University Paris 7 with Masters of Science in Genetics and Immunology.

 

Niall Murphy
Chief Scientific Officer

PhD in neuroendocrinology, more than 20 years experience in preclinical research in neurological and psychobiological disorders. Co-author of over 55 articles on addiction, Parkinson's disease, neuropathic pain, depression, anxiety and placebo effects. Adjunct Professor in the Department of Psychiatry and Biobehavioral Sciences at UCLA and former unit leader at RIKEN Brain Science Institute, Japan.

Rodolphe Hajj
Chief Pharmacology Officer

More than 13 years experience in fundamental research and drug discovery & development in stem cells, respiratory research, cystic fibrosis, cancer and neurology in academia and industry. He was in charge of the Cancer Stem Cell project at Sanofi, then led at Servier the High Content Cellular imaging platform for different disease areas.

René Goedkoop
Chief Medical Officer

More than 25 years of experience in clinical product development for inflammatory diseases including rare CNS disorders, cancer and cardiovascular diseases in start-up and large biopharmaceutical companies (Centocor, Eli Lilly, Serono, Modex, Apoxis). As an independent consultant, he conducted due diligences and helped develop business plans for de novo biotech companies.

Serguei Nabirotchkin
Co-founder, Chief Biology Officer

Specialist in experimental genetics, cell signaling and systems biology. Graduated from the Moscow State University, former leader scientist at the Institute of Molecular Biology in Moscow (Russia), DKFZ (Germany), Gustave Roussy Institute (France) and Genset (France). Former Director of the Animal Model Department at the Serono Genetics Institute.

Mickaël Guedj
Chief Data Officer

More than 12 years experience in Biostatistics and Bioinformatics, graduated of INSA-Lyon and PhD in Statistical Genetics. Fomerly at Merck-Serono and the French League against Cancer, he joined Pharnext in 2009. Expert in the analysis of biological and clinical data, adjunct lecturer at ENSAI since 2005 and co-autor of more than 50 articles.